Skip to search formSkip to main contentSkip to account menu

bleomycin/dacarbazine/doxorubicin/vinblastine protocol

Known as: ABVD, ABVD Regimen, Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen 
A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (1)

ABVD protocol
Adult Hodgkin LymphomaBleomycinDacarbazineDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
Much focus has been on the interaction of programmed cell death ligand 1 (PD-L1) on malignant B cells with programmed cell death… 
Review
2017
Review
2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
BACKGROUND Brentuximab vedotin is an anti‐CD30 antibody–drug conjugate that has been approved for relapsed and refractory Hodgkin… 
Highly Cited
2011
Highly Cited
2011
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
BACKGROUND BEACOPP, an intensified regimen consisting of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine… 
Highly Cited
2009
Highly Cited
2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
PURPOSE To compare doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) versus bleomycin, etoposide, doxorubicin… 
Highly Cited
2004
Highly Cited
2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA…
To determine whether combined modality therapy (CMT) is superior to chemotherapy (CT) alone, 152 untreated Hodgkin disease… 
Highly Cited
2003
Highly Cited
2003
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma…
PURPOSE To investigate whether radiotherapy can be reduced without loss of efficacy from extended field (EF) to involved field… 
Highly Cited
1989
Highly Cited
1989
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
From 1964 to 1987, the EORTC Lymphoma Group conducted four consecutive controlled clinical trials on clinical stages I and II… 
Highly Cited
1987
Highly Cited
1987
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly… 
Highly Cited
1985
Highly Cited
1985
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
Highly Cited
1982
Highly Cited
1982
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Of 75 consecutive patients with Stage IV Hodgkin's disease, we assigned 38 to receive MOPP alone (mechlorethamine, vincristine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)